×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Minimally Invasive Devices Market

    ID: MRFR/HC/42039-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Minimally Invasive Devices Market Research Report By Application (Cardiology, Orthopedics, Gastroenterology, Neurology, Urology), By Type (Endoscopic Devices, Bioresorbable Stents, Laparoscopic Instruments, Needle Guidance Systems), By Technique (Robotic Surgery, Natural Orifice Transluminal Endoscopic Surgery, Laparoscopic Surgery, Endoscopic Mucosal Resection), By End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Minimally Invasive Devices Market Infographic
    Purchase Options

    Minimally Invasive Devices Market Summary

    As per MRFR analysis, the Minimally Invasive Devices Market was estimated at 46.58 USD Billion in 2024. The Minimally Invasive Devices industry is projected to grow from 48.64 USD Billion in 2025 to 75.03 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.43 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Minimally Invasive Devices Market is poised for substantial growth driven by technological advancements and increasing patient-centric approaches.

    • Technological advancements are enhancing the efficacy and safety of minimally invasive devices, particularly in cardiology.
    • North America remains the largest market, while the Asia-Pacific region is emerging as the fastest-growing area for these devices.
    • Cardiology leads the market in terms of size, whereas gastroenterology is witnessing the fastest growth in demand.
    • The rising demand for minimally invasive procedures and the aging population are key drivers propelling market expansion.

    Market Size & Forecast

    2024 Market Size 46.58 (USD Billion)
    2035 Market Size 75.03 (USD Billion)
    CAGR (2025 - 2035) 4.43%

    Major Players

    Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Smith & Nephew (GB), Zimmer Biomet (US), Olympus Corporation (JP)

    Minimally Invasive Devices Market Trends

    The Minimally Invasive Devices Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing preference for less invasive surgical procedures. This market encompasses a wide array of devices designed to reduce patient recovery time, minimize scarring, and enhance overall surgical outcomes. As healthcare providers and patients alike seek alternatives to traditional surgical methods, the demand for these innovative solutions appears to be on the rise. Furthermore, the integration of robotics and imaging technologies into surgical practices is likely to further propel market growth, as these tools enhance precision and efficiency in procedures. In addition to technological advancements, the Minimally Invasive Devices Market is influenced by a growing awareness of the benefits associated with minimally invasive techniques. Patients are increasingly informed about their treatment options, leading to a shift in preferences towards procedures that promise quicker recovery and reduced hospital stays. This trend is further supported by healthcare policies that emphasize cost-effectiveness and improved patient outcomes. As the market evolves, it seems poised to expand, driven by continuous innovation and a commitment to enhancing patient care.

    Technological Advancements

    The Minimally Invasive Devices Market is witnessing rapid technological advancements, particularly in the fields of robotics and imaging. These innovations enhance the precision and effectiveness of surgical procedures, making them more appealing to both healthcare providers and patients.

    Patient-Centric Approaches

    There is a noticeable shift towards patient-centric approaches within the Minimally Invasive Devices Market. Patients are increasingly seeking procedures that offer quicker recovery times and less discomfort, influencing the development and adoption of new devices.

    Regulatory Support

    Regulatory bodies are playing a crucial role in the Minimally Invasive Devices Market by streamlining approval processes for new technologies. This support encourages innovation and facilitates the introduction of advanced devices into the market, ultimately benefiting patient care.

    Minimally Invasive Devices Market Drivers

    Aging Population and Chronic Diseases

    The aging population and the rising prevalence of chronic diseases are significant factors influencing the Minimally Invasive Devices Market. As the global population ages, the incidence of age-related conditions such as cardiovascular diseases, diabetes, and orthopedic disorders increases. This demographic shift is expected to drive the demand for minimally invasive surgical interventions, as older patients often prefer less invasive options that facilitate quicker recovery. Reports indicate that by 2030, the number of individuals aged 65 and older will reach approximately 1.5 billion, further amplifying the need for effective medical solutions. Consequently, the Minimally Invasive Devices Market is likely to experience substantial growth as healthcare systems adapt to meet the needs of this demographic.

    Technological Innovations in Device Design

    Technological innovations play a crucial role in shaping the Minimally Invasive Devices Market. The development of advanced materials, robotics, and imaging technologies has led to the creation of more effective and precise devices. For instance, the integration of robotic-assisted surgical systems has revolutionized surgical procedures, allowing for greater precision and control. The market for robotic surgical systems alone is anticipated to exceed USD 20 billion by 2025. Furthermore, innovations in imaging technologies, such as 3D visualization and augmented reality, enhance the surgeon's ability to perform complex procedures with minimal invasiveness. These technological advancements not only improve patient outcomes but also drive the demand for new devices, thereby contributing to the growth of the Minimally Invasive Devices Market.

    Increased Focus on Patient Safety and Outcomes

    The heightened focus on patient safety and outcomes is a pivotal driver of the Minimally Invasive Devices Market. Healthcare providers are increasingly prioritizing techniques that minimize risks and enhance recovery experiences for patients. Minimally invasive procedures are associated with lower rates of infection, reduced blood loss, and quicker recovery times, which align with the growing emphasis on patient-centered care. As hospitals and clinics strive to improve their quality of care metrics, the demand for devices that facilitate these procedures is likely to rise. This trend is further supported by regulatory bodies advocating for safer surgical practices, thereby reinforcing the growth trajectory of the Minimally Invasive Devices Market.

    Rising Demand for Minimally Invasive Procedures

    The increasing preference for minimally invasive procedures is a primary driver of the Minimally Invasive Devices Market. Patients are increasingly opting for these procedures due to their associated benefits, such as reduced recovery times, lower risk of complications, and minimal scarring. According to recent data, the market for minimally invasive surgical devices is projected to reach approximately USD 50 billion by 2026, reflecting a compound annual growth rate of around 8%. This trend is further fueled by advancements in surgical techniques and technologies, which enhance the efficacy and safety of these procedures. As healthcare providers continue to adopt minimally invasive methods, the demand for specialized devices is expected to grow, thereby propelling the Minimally Invasive Devices Market forward.

    Cost-Effectiveness of Minimally Invasive Procedures

    The cost-effectiveness of minimally invasive procedures serves as a compelling driver for the Minimally Invasive Devices Market. These procedures typically result in shorter hospital stays, reduced need for postoperative care, and lower overall healthcare costs. Studies have shown that hospitals can save up to 30% on costs associated with surgical procedures when utilizing minimally invasive techniques. As healthcare providers seek to optimize resource allocation and improve patient outcomes, the adoption of minimally invasive devices becomes increasingly attractive. This economic advantage not only benefits healthcare systems but also encourages patients to choose these options, thereby fostering growth within the Minimally Invasive Devices Market.

    Market Segment Insights

    By Application: Cardiology (Largest) vs. Gastroenterology (Fastest-Growing)

    The Minimally Invasive Devices Market showcases a diverse application landscape, with cardiology commanding the largest share. This segment has consistently leveraged technological advancements, yielding a robust adoption rate among healthcare providers and patients alike. Following closely is orthopedics, which has also captured significant attention, while urology, neurology, and gastroenterology represent emerging opportunities demonstrating increased penetration rates. The shift towards less invasive procedures is steadily reshaping the competitive dynamics, influencing market strategies.

    Cardiology (Dominant) vs. Gastroenterology (Emerging)

    Cardiology remains the dominant application within the Minimally Invasive Devices Market, characterized by continuous innovation, enhanced procedural safety, and improved patient outcomes. This segment benefits from a growing prevalence of cardiovascular diseases, driving demand for advanced devices that minimize patient recovery time. Conversely, gastroenterology is emerging as a rapidly growing application, fueled by rising awareness and advancements in endoscopic procedures. The integration of cutting-edge technologies, such as robotics and advanced imaging, empowers gastroenterologists to conduct safer procedures with enhanced precision, making this segment increasingly attractive to key stakeholders in the medical device industry.

    By Type: Endoscopic Devices (Largest) vs. Bioresorbable Stents (Fastest-Growing)

    In the Minimally Invasive Devices Market, Endoscopic Devices hold the largest market share, being widely adopted due to their effectiveness in visualization and diagnosis. Following this, Bioresorbable Stents represent the fastest-growing segment as they offer significant advantages over traditional stents, including the reduction of long-term complications and enhanced patient comfort.

    Endoscopic Devices (Dominant) vs. Bioresorbable Stents (Emerging)

    Endoscopic Devices are crucial in minimally invasive surgeries, providing high-definition imaging and precise navigation through internal structures. They dominate the market due to their extensive applications in gastroenterology and pulmonology. On the other hand, Bioresorbable Stents are gaining traction as an innovative solution for vascular interventions, as they dissolve within the body after serving their purpose, thus minimizing the need for long-term implantation. The growing focus on patient-centered care and reduced complications is driving the increasing adoption of these emerging devices.

    By Technique: Laparoscopic Surgery (Largest) vs. Robotic Surgery (Fastest-Growing)

    The Minimally Invasive Devices Market showcases a diverse range of techniques, among which laparoscopic surgery holds the largest market share. This technique has established itself as the gold standard for various surgical procedures, thanks to its wide application across different fields such as gynecology, urology, and general surgery. It is preferred for its numerous benefits including reduced recovery time, lower complication rates, and minimal scarring, making it a top choice for both surgeons and patients. In contrast, robotic surgery is identified as the fastest-growing segment in this market. It encompasses advanced systems that allow surgeons to perform intricate procedures with enhanced precision and control. The rising demand for minimally invasive surgery, coupled with technological advancements in robotic systems, is propelling this segment's growth, as hospitals seek to adopt technologies that improve patient outcomes and operational efficiencies.

    Laparoscopic Surgery (Dominant) vs. Natural Orifice Transluminal Endoscopic Surgery (Emerging)

    Laparoscopic surgery has long been a dominant force within the Minimally Invasive Devices Market, known for its efficacy and versatility across multiple medical fields. This technique allows for surgeries to be performed through small incisions, equipped with a high-definition camera and specialized instruments. Its established advantages such as shorter hospital stays and quicker recovery times have solidified its position as the preferred surgical method. On the other hand, natural orifice transluminal endoscopic surgery (NOTES) is an emerging technique that utilizes the body's natural openings for surgical access. Although still in the early stages of adoption, NOTES presents significant potential due to its promise of no visible scars and reduced pain associated with traditional methods. As surgeon experience with this technique grows and its benefits become more widely recognized, it may challenge the long-standing dominance of laparoscopic surgery in the future.

    By End Use: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

    In the Minimally Invasive Devices Market, hospitals represent the largest segment, showcasing a significant share due to their extensive surgical services and advanced surgical technologies. This segment benefits from a high volume of surgical procedures performed annually. In contrast, Ambulatory Surgical Centers (ASCs) are rapidly gaining ground, driven by their ability to provide same-day discharge and lower costs, attracting a growing patient population seeking less invasive options.

    Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

    Hospitals remain the dominant end-use segment for minimally invasive devices, primarily due to their comprehensive patient care and advanced surgical capabilities. The substantial funding for equipment, skilled personnel, and research in hospitals supports their leading position. On the other hand, Ambulatory Surgical Centers are emerging as a vital segment, offering convenience and cost-effectiveness. They specialize in outpatient procedures, reducing the need for extended hospital stays. As more patients opt for procedures that permit quicker recovery times, ASC usage is likely to expand significantly, challenging traditional hospital practices.

    Get more detailed insights about Minimally Invasive Devices Market

    Regional Insights

    The Regional segmentation of the Global Minimally Invasive Devices Market reveals significant insights and valuation trends across diverse geographical locations. In 2024, the North America region is poised to dominate with a valuation of 20.0 USD Billion, expected to grow to 32.0 USD Billion by 2035, showcasing a major demand for advanced healthcare technology.

    Europe follows closely, valued at 12.0 USD Billion in 2024 and projected to reach 19.0 USD Billion by 2035, highlighting the importance of innovation and regulatory advancements in the region.The APAC market, valued at 10.0 USD Billion in 2024 with a forecast of 18.0 USD Billion in 2035, reflects the rising adoption of minimally invasive procedures due to improving healthcare infrastructure and increasing patient awareness.

    In contrast, South America and MEA represent smaller yet significant portions of the market, with valuations of 2.5 USD Billion and 2.08 USD Billion in 2024, growing to 4.0 USD Billion and 2.5 USD Billion by 2035, respectively. This underscores emerging opportunities for market expansion in these regions, albeit at a slower growth rate.Overall, these insights into the Global Minimally Invasive Devices Market segmentation indicate a diverse landscape of growth and innovation tailored to specific regional needs.

    Minimally Invasive Devices Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Minimally Invasive Devices Market Regional Image

    Key Players and Competitive Insights

    The competitive insights of the Global Minimally Invasive Devices Market reveal a dynamic and rapidly evolving landscape characterized by technological advancements, rising patient demand for less invasive treatment options, and an increasing prevalence of chronic diseases.

    As healthcare providers aim to improve patient outcomes while minimizing recovery times, companies in this market are investing significantly in research and development to innovate and enhance their product offerings. The landscape is also shaped by strategic collaborations, mergers and acquisitions, and the entry of new players seeking to capture market share.

    Regulatory factors and reimbursement policies play a critical role in shaping competitive strategies as companies navigate the complexities of market entry and product approval.Intuitive Surgical stands out in the Global Minimally Invasive Devices Market with its pioneering role in robotic-assisted surgical systems. The company has established a robust market presence through its flagship product, which emphasizes precision and enhanced surgical capabilities.

    Intuitive Surgical benefits from a strong brand reputation built on a foundation of innovation and a commitment to improving surgical outcomes. The extensive training programs offered by the company for healthcare professionals ensure that surgeons are proficient in using its systems, thereby increasing adoption rates. Moreover, Intuitive Surgical has cultivated a vast network of users and institutions, enabling it to maintain a competitive edge through knowledge sharing and continuous feedback that drives further product enhancements.

    Hologic is another key player in the Global Minimally Invasive Devices Market, mainly known for its focus on women's health. The company has successfully developed advanced technologies that aim to address a variety of conditions through minimally invasive procedures, thereby improving patient comfort and recovery times. Hologic's strength lies in its comprehensive portfolio of innovative devices designed to meet patient needs and the increasing demand for effective, less invasive treatments.

    By leveraging its expertise in diagnostics and surgery, Hologic manages to provide integrated solutions that resonate well with healthcare providers and patients alike. The company’s commitment to advancing gynecological health also positions it favorably in a niche market where specialized devices can play a pivotal role in treatment outcomes.

    Key Companies in the Minimally Invasive Devices Market market include

    Industry Developments

    • Q2 2024: Olympus Launches POWERSEAL™ Sealer/Divider for Minimally Invasive Surgery in Europe Olympus announced the European launch of its POWERSEAL™ Sealer/Divider, a new device designed to improve vessel sealing and tissue management in minimally invasive surgical procedures.
    • Q2 2024: Intuitive Announces FDA Clearance for da Vinci 5 Surgical System Intuitive received FDA clearance for its da Vinci 5, the latest generation of its robotic-assisted surgical system, expanding its offerings for minimally invasive procedures.
    • Q2 2024: Medtronic Receives CE Mark for Hugo™ Robotic-Assisted Surgery System Medtronic announced it has received CE Mark approval for its Hugo™ robotic-assisted surgery system, enabling its commercialization for minimally invasive procedures in Europe.
    • Q1 2024: Boston Scientific Completes Acquisition of Apollo Endosurgery Boston Scientific completed its acquisition of Apollo Endosurgery, expanding its portfolio of minimally invasive devices for gastrointestinal and bariatric procedures.
    • Q1 2024: Johnson & Johnson MedTech launches Ottava robotic surgical system clinical trial Johnson & Johnson MedTech announced the start of clinical trials for its Ottava robotic surgical system, designed for minimally invasive surgery.
    • Q2 2024: Stryker Announces Opening of New R&D Facility Focused on Minimally Invasive Surgery Stryker opened a new research and development facility dedicated to advancing minimally invasive surgical devices and technologies.
    • Q2 2024: Asensus Surgical Announces Partnership with Google Cloud to Advance Digital Surgery Asensus Surgical entered a partnership with Google Cloud to leverage artificial intelligence and cloud computing for enhancing digital minimally invasive surgery platforms.
    • Q1 2024: Smith+Nephew Receives FDA Clearance for CORI Digital Tensioner for Knee Arthroplasty Smith+Nephew received FDA clearance for its CORI Digital Tensioner, a device designed to improve outcomes in minimally invasive knee replacement surgeries.
    • Q2 2024: NuVasive Launches Pulse Platform 2.0 for Minimally Invasive Spine Surgery NuVasive launched Pulse Platform 2.0, an integrated technology platform designed to support minimally invasive spine surgery procedures.
    • Q1 2024: Medtronic Announces FDA Approval of Symplicity Spyral Renal Denervation System Medtronic received FDA approval for its Symplicity Spyral Renal Denervation System, a minimally invasive device for the treatment of hypertension.
    • Q2 2024: CONMED Acquires Biorez, Expanding Soft Tissue Healing Portfolio CONMED completed the acquisition of Biorez, a company specializing in bio-inductive implants for minimally invasive soft tissue repair.
    • Q1 2024: Zimmer Biomet Announces FDA Clearance of ROSA Shoulder System Zimmer Biomet received FDA clearance for its ROSA Shoulder System, a robotic platform designed to assist surgeons in minimally invasive shoulder replacement procedures.

    Future Outlook

    Minimally Invasive Devices Market Future Outlook

    The Minimally Invasive Devices Market is projected to grow at a 4.43% CAGR from 2024 to 2035, driven by technological advancements, increasing patient preference, and rising healthcare expenditures.

    New opportunities lie in:

    • Expansion of telehealth integration for remote monitoring solutions.
    • Development of advanced robotic-assisted surgical systems.
    • Investment in biodegradable materials for device manufacturing.

    By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare demands.

    Market Segmentation

    Minimally Invasive Devices Market Type Outlook

    • Endoscopic Devices
    • Bioresorbable Stents
    • Laparoscopic Instruments
    • Needle Guidance Systems

    Minimally Invasive Devices Market End Use Outlook

    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics

    Minimally Invasive Devices Market Technique Outlook

    • Robotic Surgery
    • Natural Orifice Transluminal Endoscopic Surgery
    • Laparoscopic Surgery
    • Endoscopic Mucosal Resection

    Minimally Invasive Devices Market Application Outlook

    • Cardiology
    • Orthopedics
    • Gastroenterology
    • Neurology
    • Urology

    Report Scope

    MARKET SIZE 202446.58(USD Billion)
    MARKET SIZE 202548.64(USD Billion)
    MARKET SIZE 203575.03(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.43% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in robotic-assisted surgery enhance precision and expand applications in the Minimally Invasive Devices Market.
    Key Market DynamicsTechnological advancements drive competitive forces, enhancing minimally invasive device adoption and reshaping surgical practices.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Leave a Comment

    FAQs

    What is the projected market valuation for the Minimally Invasive Devices Market in 2035?

    The projected market valuation for the Minimally Invasive Devices Market in 2035 is 75.03 USD Billion.

    What was the overall market valuation for the Minimally Invasive Devices Market in 2024?

    The overall market valuation for the Minimally Invasive Devices Market in 2024 was 46.58 USD Billion.

    What is the expected CAGR for the Minimally Invasive Devices Market during the forecast period 2025 - 2035?

    The expected CAGR for the Minimally Invasive Devices Market during the forecast period 2025 - 2035 is 4.43%.

    Which application segment is projected to have the highest valuation by 2035?

    The Urology application segment is projected to reach 21.03 USD Billion by 2035.

    What is the projected valuation for laparoscopic instruments by 2035?

    The projected valuation for laparoscopic instruments is expected to be 20.0 USD Billion by 2035.

    Which company is a key player in the Minimally Invasive Devices Market?

    Medtronic is one of the key players in the Minimally Invasive Devices Market.

    What is the expected valuation for robotic surgery by 2035?

    The expected valuation for robotic surgery is projected to be 16.0 USD Billion by 2035.

    What is the projected market size for endoscopic devices in 2035?

    The projected market size for endoscopic devices is anticipated to reach 24.0 USD Billion by 2035.

    Which end-use segment is expected to grow significantly by 2035?

    The Hospitals end-use segment is expected to grow significantly, reaching 29.0 USD Billion by 2035.

    What is the projected valuation for bioresorbable stents by 2035?

    The projected valuation for bioresorbable stents is expected to be 15.0 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions